Literature DB >> 10469157

Fibrinolytic properties of activated FXII.

E A Braat1, G Dooijewaard, D C Rijken.   

Abstract

Activated factor XII (FXIIa), the initiator of the contact activation system, has been shown to activate plasminogen in a purified system. However, the quantitative role of FXIIa as a plasminogen activator in contact activation-dependent fibrinolysis in plasma is still unclear. In this study, the plasminogen activator (PA) activity of FXIIa was examined both in a purified system and in a dextran sulfate euglobulin fraction of plasma by measuring fibrinolysis in a fibrin microtiter plate assay. FXIIa was found to have low PA activity in a purified system. Dextran sulfate potentiated the PA activity of FXIIa about sixfold, but had no effect on the PA activity of smaller fragments of FXIIa, missing the binding domain for negatively charged surfaces. The addition of small amounts of factor XII (FXII) to FXII-deficient plasma induced a large increase in contact activation-dependent PA activity, as measured in a dextran sulfate euglobulin fraction, which may be ascribed to FXII-dependent activation of plasminogen activators like prekallikrein. When more FXII was added, PA activity continued to increase but to a lesser extent. In normal plasma, the addition of FXII also resulted in an increase of contact activation-dependent PA activity. These findings suggested a significant contribution of FXIIa as a direct plasminogen activator. Indeed, at least 20% of contact activation-dependent PA activity could be extracted from a dextran sulfate euglobulin fraction prepared from normal plasma by immunodepletion of FXIIa and therefore be ascribed to direct PA activity of FXIIa. PA activity of endogenous FXIIa immunoadsorped from plasma could only be detected in the presence of dextran sulfate. From these results it is concluded that FXIIa can contribute significantly to fibrinolysis as a plasminogen activator in the presence of a potentiating surface.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10469157     DOI: 10.1046/j.1432-1327.1999.00593.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  11 in total

1.  A positively charged cluster in the epidermal growth factor-like domain of Factor VII-activating protease (FSAP) is essential for polyanion binding.

Authors:  Boran Altincicek; Aya Shibamiya; Heidi Trusheim; Eleni Tzima; Michael Niepmann; Dietmar Linder; Klaus T Preissner; Sandip M Kanse
Journal:  Biochem J       Date:  2006-03-15       Impact factor: 3.857

2.  Investigation of tissue factor and other hemostatic profiles in experimental hypothyroidism.

Authors:  A Ata Alturfan; Ebru Emekli Alturfan; Nuran Dariyerli; Emel Zengin; Erman Aytac; Gunnur Yigit; Emine Kokoglu
Journal:  Endocrine       Date:  2006-08       Impact factor: 3.633

Review 3.  The many faces of the contact pathway and their role in thrombosis.

Authors:  Rebecca S Woodruff; Bruce Sullenger; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2011-07       Impact factor: 2.300

4.  Polyphosphate colocalizes with factor XII on platelet-bound fibrin and augments its plasminogen activator activity.

Authors:  Joanne L Mitchell; Ausra S Lionikiene; Georgi Georgiev; Anja Klemmer; Chelsea Brain; Paul Y Kim; Nicola J Mutch
Journal:  Blood       Date:  2016-09-30       Impact factor: 22.113

5.  Donor-to-recipient transmission of factor XII deficiency by orthotopic liver transplantation.

Authors:  Hussien Elsiesy; Mohamed Shawakat; Waleed Alhamoudi; Mohamed Alsebayel; John Renz; Hany Elbeshbeshy; Mohamed Abdelfattah; Faisal Abaalkhail
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-08-19

6.  The effects of continuous venovenous hemofiltration on coagulation activation.

Authors:  Catherine S C Bouman; Anne-Cornélie J M de Pont; Joost C M Meijers; Kamran Bakhtiari; Dorina Roem; Sacha Zeerleder; Gertjan Wolbink; Johanna C Korevaar; Marcel Levi; Evert de Jonge
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

Review 7.  The Mast Cell, Contact, and Coagulation System Connection in Anaphylaxis.

Authors:  Mar Guilarte; Anna Sala-Cunill; Olga Luengo; Moisés Labrador-Horrillo; Victoria Cardona
Journal:  Front Immunol       Date:  2017-07-26       Impact factor: 7.561

8.  Genotyping analysis for the 46 C/T polymorphism of coagulation factor XII and the involvement of factor XII activity in patients with recurrent pregnancy loss.

Authors:  Eriko Asano; Takeshi Ebara; Chisato Yamada-Namikawa; Tamao Kitaori; Nobuhiro Suzumori; Kinue Katano; Yasuhiko Ozaki; Makoto Nakanishi; Mayumi Sugiura-Ogasawara
Journal:  PLoS One       Date:  2014-12-09       Impact factor: 3.240

Review 9.  Bradykinin: Inflammatory Product of the Coagulation System.

Authors:  Zonne Hofman; Steven de Maat; C Erik Hack; Coen Maas
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 8.667

Review 10.  Thromboplasminflammation in COVID-19 Coagulopathy: Three Viewpoints for Diagnostic and Therapeutic Strategies.

Authors:  Satoshi Gando; Takeshi Wada
Journal:  Front Immunol       Date:  2021-06-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.